Applied Clinical Trials Trends / Having trouble viewing this e-mail? Click Here

In this ISSUE

Pandemic Highlights Urgency for New Methodologies for Evidence Generation

EMA Wins Points for Its COVID-19 Responsiveness

DMCs: Maintaining Data Integrity in COVID-19 Climate
From the Editor
COVID Overload in Research
With the bevy of coronavirus-specific information, databases and trackers, registries, and other tools out there at the moment, the challenge in store is integrating these resources to help in both clinical care response and informing drug intervention in real-time.
... /Read more/

Q&A
How Biopharma is Adapting to COVID
Tom Rhodes, CEO of Spencer Health Solutions, discusses his experiences on how the biopharmaceutical industry has been impacted by COVID, and what some are doing to succeed.
... /Read more/

Risk-based Monitoring
Central RBM Supports Reduced Cost, Higher Data Quality
Implementing centralized risk-based monitoring can help meet strict GCP requirements for study conduct, oversight, and recording.
... /Read more/

Coronavirus
Impact on Trials in Europe after COVID-19?
A panel of European experts reflect on the impact of the COVID-19 outbreak on clinical trials, now and in the future.
... /Read more/

Blogs
Save Sites Now to Preserve the Future of Clinical Trials
CEO and founder of Phesi, Gen Li, shares his insights drawn from analyzed data from 300,000 global sites to assess the current COVID-19 situation that has shown an increase in site suspensions over the past two months.
... /Read more/
Calendar
/ DIA 2020 Global Annual Meeting — 6/14-6/18 /
/ 18th Annual Independent Medical Education & Grants Summit — 9/22-9/23 /


Ask the editor
Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise
Todd Baker
Group Publisher
tbaker@mmhgroup.com


Advertisement
Bioforum, the Forum for EmergingBio's Outsourcing Decisions
As the biopharma industry traverses unchartered waters amid the COVID-19 crisis and doubles down on its efforts to bring new therapies to market faster, cheaper and without affecting quality, the success of strategic partnerships and functional service provider models will become more critical than ever before.
Read the article

website / blog / advertise / subscribe